Evaluation of the Finnish newborn BCG vaccination programme

[1]  N. Qualls,et al.  Outcomes of contact investigations of infectious tuberculosis patients. , 2000, American journal of respiratory and critical care medicine.

[2]  D. Mitchison.  Role of individual drugs in the chemotherapy of tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  I. Onorato,et al.  Extensive transmission of Mycobacterium tuberculosis from a child. , 1999, The New England journal of medicine.

[4]  H. Whittle,et al.  Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. , 1999, The Journal of infectious diseases.

[5]  H. Rieder,et al.  Epidemiologic basis of tuberculosis control , 1999 .

[6]  M. Tala-Heikkilä,et al.  Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence. , 1998, American journal of respiratory and critical care medicine.

[7]  H. Whittle,et al.  Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.

[8]  I. Onorato,et al.  An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. , 1998, The New England journal of medicine.

[9]  J. Zellweger.  Pathogenesis and transmission of tuberculosis. , 1997 .

[10]  L. M. Andrade,et al.  Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. , 1996, American journal of respiratory and critical care medicine.

[11]  P. E. M. Fine,et al.  Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[12]  H. Hallander,et al.  Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  C S Berkey,et al.  The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.

[14]  W. Stead,et al.  The Risk for Transmission of Mycobacterium tuberculosis at the Bedside and during Autopsy , 1995, Annals of Internal Medicine.

[15]  G. Colditz,et al.  Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  E. Svandova,et al.  Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  G. Schoolnik,et al.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.

[18]  D. Snider,et al.  Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. , 1994, American journal of respiratory and critical care medicine.

[19]  Miller Bess,et al.  Preventive therapy for tuberculosis. , 1993, The Medical clinics of North America.

[20]  E. Svandova,et al.  Six years' experience with the discontinuation of BCG vaccination. 2. Cost and benefit of mass BCG vaccination. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  K. Liippo,et al.  Focusing tuberculosis contact tracing by smear grading of index cases. , 1993, The American review of respiratory disease.

[22]  E. Svandova,et al.  Six years' experience with the discontinuation of BCG vaccination , 1993 .

[23]  A. Fasth,et al.  Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in Sweden , 1993, Acta paediatrica.

[24]  E. Tala,et al.  Evaluation of the BCG revaccination programme of schoolchildren in Finland. , 1991, Bulletin of the International Union against Tuberculosis and Lung Disease.

[25]  I. Sutherland,et al.  The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates. , 1989, Journal of epidemiology and community health.

[26]  H. Landmann,et al.  The effects of systematic BCG vaccination of newborns on the incidence of postprimary tuberculosis meningitis in childhood. , 1988, Bulletin of the International Union against Tuberculosis and Lung Disease.

[27]  M. Katila,et al.  Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood. , 1987, Tubercle.

[28]  I. Sutherland,et al.  Effectiveness of BCG vaccination in England and Wales in 1983. , 1987, Tubercle.

[29]  H. Peltola,et al.  BCG vaccination as a cause of osteomyelitis and subcutaneous abscess. , 1984, Archives of disease in childhood.

[30]  O. Wasz‐Höckert,et al.  BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. , 1984, Advances in tuberculosis research. Fortschritte der Tuberkuloseforschung. Progres de l'exploration de la tuberculose.

[31]  V. Romanus.  Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn. , 1983, Tubercle.

[32]  A. Feinstein,et al.  The BCG controversy. A methodological and statistical reappraisal. , 1983, JAMA.

[33]  A. Rouillon,et al.  BCG vaccination and epidemiological situation: a decision making approach to the use of BCG. , 1976, Advances in tuberculosis research. Fortschritte der Tuberkuloseforschung. Progres de l'exploration de la tuberculose.

[34]  P. D. Hart,et al.  The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines , 1967 .